Supporting Indigenous Communities: LifeLabs’ Efforts to Provide Health Equity on National Day of Truth and Reconciliation 
Dr. Sanaz Cordes Named Chief Executive Officer Of DotCom Therapy
MADISON, Wis., April 4, 2019 /PRNewswire/ -- DotCom Therapy, Inc., an industry leader in teletherapy for speech, occupational, and behavioral health...
Providence St. Joseph Health Makes Same-Day Express Care Appointment Scheduling Available On Amazon Alexa
RENTON, Wash., April 4, 2019 /PRNewswire/ -- Providence St. Joseph Health (PSJH), one of the nation's largest health systems, has teamed up...
Greenphire Launches New Tax Capability to Ease Administrative Burden and Improve Compliance for Clinical Trial Industry
KING OF PRUSSIA, Pa., April 4, 2019 /PRNewswire/ -- Greenphire, the global leader in financial software for clinical trials, announced today...
Spheryx Introduces xSight, a Revolutionary Particle Characterization Instrument, with Live Demonstrations at the 10th Annual PEGS Boston, April 8-12, 2019.
NEW YORK, April 4, 2019 /PRNewswire/ -- Spheryx, Inc. will demonstrate xSight, their particle characterization instrument at PEGS Boston, April 8-12,...
NetNoggin® research to be presented at the 2019 Alzheimer’s Association International Conference
FREDERICK, Md., April 4, 2019 /PRNewswire/ -- NetNoggin® announced they will present additional findings from their Alzheimer's disease research report at...
Volpara Solutions Celebrates 10 Years of Striving to Save Families from Breast Cancer
WELLINGTON, New Zealand, April 4, 2019 /PRNewswire/ -- Celebrating its 10th Anniversary in 2019, Volpara Solutions remains committed to helping breast imaging...
Synchron Initiates First-ever Clinical Trial to Evaluate Thought-to-Text™ Brain-Computer Interface Technology in Patients with Severe Paralysis
SAN FRANCISCO and NEW YORK and MELBOURNE, Australia, April 8, 2019 /PRNewswire/ -- Synchron, Inc. today announced the initiation of the...
The University of Iowa Carver College of Medicine Improves Student Exam Scores with Gale Interactive: Human Anatomy
FARMINGTON HILLS, Mich. and IOWA CITY, Iowa, April 8, 2019 /PRNewswire/ -- The University of Iowa Carver College of Medicine has...
Alzheimer’s Research About to Reach Crushing Speeds
REDMOND, Wash., April 8, 2019 /PRNewswire/ -- On April 13 thousands will join the "Megathon" event from home and in public...
Identifying Grass Pollen That Gets Up Your Nose
First results of a major three-year project to analyze airborne grass pollen LONDON, UK / ACCESSWIRE / April 8, 2019...
Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives
LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company...
Easton Provides Update on the Closing of its Agreement To Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market
TORONTO, ON / ACCESSWIRE / April 8, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides update on the closing...
EFX Laboratories Commences Commercial Capsule Sales Through Strategic Partnership
VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
Virpax(R) Pharmaceuticals Announces R&D Collaborative Initiative with Kannaba Technologies
Companies to Combine Cutting-Edge Delivery Technologies, Coupled with Advanced Computational Capabilities and Robotics for Development of Innovative Cannabinoid-Based Biopharmaceuticals MALVERN,...
Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman to Board of Directors
Mr. Goldman also joins newly formed Board special committee established to evaluate strategic options LIVINGSTON, NJ / ACCESSWIRE / April...
ORYZON to Present First in Human Efficacy Data with Vafidemstat at the 27th European Congress of Psychiatry in Warsaw
Efficacy data from the REIMAGINE Phase IIa basket trial's Borderline Personality Disorder (BPD) cohort Vafidemstat is an active compound in...
Oncolytics Biotech(R) Announces First Patient Treated in Company’s AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer
- Study to generate comprehensive biomarker data by breast cancer sub-type to support phase 3 registration program - Interim data...
EVITRADE Signs LOI with Medical Delivery App and Update on Time-Release Drug Delivery System Joint Venture
VANCOUVER, BC / ACCESSWIRE / April 5, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Year Ended 31 December 2018 and 2019 Guidance
Parnell Delivers 39% Revenue Growth and a $6.5 Million Improvement in EBITDA in 2018 Compared to 2017, Returns to NPAT...
Frank Magliochetti on the Potential of Pharmacogenomic Testing to Reduce Healthcare Costs
LAWRENCE, MA / ACCESSWIRE / April 4, 2019 / Healthcare spending in the United States reached $3.5 trillion in 2017,...